Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen versus mefenamic acid after bilateral mandibular implant surgery
IRCT20221223056901N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of ibuprofen and Mefenamic acid in postoperative pain (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Pain control after implant surgery, Control of swelling after implant surgery and 1 more. Started Jan 2023; status: completed.
02
Drugs
ibuprofenMefenamic acid
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221223056901N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221223056901N1.